257 related articles for article (PubMed ID: 31864680)
1. Insight into the Structural Features of TSPO: Implications for Drug Development.
Lacapere JJ; Duma L; Finet S; Kassiou M; Papadopoulos V
Trends Pharmacol Sci; 2020 Feb; 41(2):110-122. PubMed ID: 31864680
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the High-Affinity Drug Ligand Binding Site of Mouse Recombinant TSPO.
Iatmanen-Harbi S; Senicourt L; Papadopoulos V; Lequin O; Lacapere JJ
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901938
[TBL] [Abstract][Full Text] [Related]
3. A unified structural model of the mammalian translocator protein (TSPO).
Xia Y; Ledwitch K; Kuenze G; Duran A; Li J; Sanders CR; Manning C; Meiler J
J Biomol NMR; 2019 Jul; 73(6-7):347-364. PubMed ID: 31243635
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
[TBL] [Abstract][Full Text] [Related]
6. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding.
Murail S; Robert JC; Coïc YM; Neumann JM; Ostuni MA; Yao ZX; Papadopoulos V; Jamin N; Lacapère JJ
Biochim Biophys Acta; 2008 Jun; 1778(6):1375-81. PubMed ID: 18420025
[TBL] [Abstract][Full Text] [Related]
7. The Ligands of Translocator Protein: Design and Biological Properties.
Mokrov GV; Deeva OA; Gudasheva TA
Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
[TBL] [Abstract][Full Text] [Related]
8. Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic Ligands.
Veenman L; Vainshtein A; Yasin N; Azrad M; Gavish M
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271616
[TBL] [Abstract][Full Text] [Related]
9. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
10. Translocator Protein 18 kDa (TSPO): An Old Protein with New Functions?
Li F; Liu J; Liu N; Kuhn LA; Garavito RM; Ferguson-Miller S
Biochemistry; 2016 May; 55(20):2821-31. PubMed ID: 27074410
[TBL] [Abstract][Full Text] [Related]
11. Translocator protein as a promising target for novel anxiolytics.
Costa B; Da Pozzo E; Martini C
Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the ligand binding sites in the translocator protein TSPO using the chimeric bacterial-mammalian constructs.
Graeber E; Korkhov VM
Protein Expr Purif; 2019 Dec; 164():105456. PubMed ID: 31326501
[TBL] [Abstract][Full Text] [Related]
13. Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)?
Scarf AM; Auman KM; Kassiou M
Curr Mol Med; 2012 May; 12(4):387-97. PubMed ID: 22348609
[TBL] [Abstract][Full Text] [Related]
14. Structure of the mammalian TSPO/PBR protein.
Jaremko M; Jaremko Ł; Jaipuria G; Becker S; Zweckstetter M
Biochem Soc Trans; 2015 Aug; 43(4):566-71. PubMed ID: 26551694
[TBL] [Abstract][Full Text] [Related]
15. Evolving understanding of translocator protein 18 kDa (TSPO).
Li F; Liu J; Garavito RM; Ferguson-Miller S
Pharmacol Res; 2015 Sep; 99():404-9. PubMed ID: 25882248
[TBL] [Abstract][Full Text] [Related]
16. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand.
Jaremko L; Jaremko M; Giller K; Becker S; Zweckstetter M
Science; 2014 Mar; 343(6177):1363-6. PubMed ID: 24653034
[TBL] [Abstract][Full Text] [Related]
17. Protein-ligand and membrane-ligand interactions in pharmacology: the case of the translocator protein (TSPO).
Hatty CR; Banati RB
Pharmacol Res; 2015 Oct; 100():58-63. PubMed ID: 26238176
[TBL] [Abstract][Full Text] [Related]
18. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers.
Hatty CR; Le Brun AP; Lake V; Clifton LA; Liu GJ; James M; Banati RB
Biochim Biophys Acta; 2014 Mar; 1838(3):1019-30. PubMed ID: 24374318
[TBL] [Abstract][Full Text] [Related]
19. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondrial energy metabolism with TSPO ligands.
Gut P
Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
